Another important cancer marker in determining the effectiveness of VPA could be the SLC5A8 co-transporter, which acts as an electrogenic sodium- and chloride-dependent sodium-coupled co-transporter [65,66]. This evidence concerns the gene SLC5A8 and cancer.